Related Experiment Video
Updated: Apr 9, 2026

07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
15.3K
[Systemic therapy of soft tissue sarcomas].
Voprosy Onkologii
|June 20, 2015
Summary
Soft tissue sarcomas (STS) are aggressive rare cancers. This paper reviews chemotherapy principles and presents treatment experiences for advanced STS patients, highlighting challenges in managing this difficult disease.
Area of Science:
- Oncology
- Medical Research
Background:
- Soft tissue sarcomas (STS) are rare, aggressive cancers originating from mesenchymal tissues.
- STS biology leads to poor prognosis due to early metastasis and limited treatment options from tumor resistance.
Purpose of the Study:
- To review current chemotherapy principles for early and metastatic soft tissue sarcomas.
- To present and discuss the authors' experience in treating advanced STS patients.
Main Methods:
- Literature review of current chemotherapy strategies for STS.
- Analysis of treatment outcomes in a cohort of advanced STS patients.
Main Results:
- Chemotherapy faces challenges due to STS aggressiveness and resistance.
- Discussion of own experience provides insights into advanced STS management.
Conclusions:
- Current chemotherapy principles for STS require careful consideration of disease stage and patient factors.
- Further research and novel therapeutic approaches are needed for advanced soft tissue sarcomas.
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies
10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Treatment Resistent Cancers
1.5K
1.5K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.8K
1.8K

